Medicare Compliance & Reimbursement

Coverage:

ICD COVERAGE EXPANDS- BUT ONLY SLIGHTLY

Health care providers will soon be able to bill Medicare for implantable cardioverter defibrillators in more circumstances. But the extent of the ICD coverage expansion is not as broad as many had hoped. The Centers for Medicare & Medicaid Services announced June 6 that it will be adding the following two indications to Medicare coverage: patients with coronary artery disease with prior myocardial infarction, left ventricular ejection fraction of less than or equal to 0.35, and inducible, sustained ventricular tachycardia or ventricular fibrillation at electrophysiological study; and patients with a prior heart attack and left ventricular ejection fraction of less than or equal to 0.30, and an electrical conduction abnormality in the heart duration of greater than 120 milliseconds. Those types of cases represent only a portion of patients studied in the Multicenter Auto matic Defibrillator Implantation Trial II. Device manufacturers Guidant Corp. and Medtronic Inc. had hoped CMS would agree to cover a much larger population.
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Medicare Compliance & Reimbursement

View All